DPT3
IMMUNISATION - SCI & TECH
News: India recorded all-time
high of 93% DPT3 immunization coverage in 2022: WHO
What's
in the news?
● According
to the World Health Organization (WHO), India’s coverage rate for the DPT3
vaccine (diphtheria, pertussis, and tetanus) reached an all-time high of 93% in
2022.
DPT3:
● The
DTP3 vaccine, protecting against diphtheria,
tetanus, and pertussis (whooping cough), serves as the standard indicator
for immunization coverage worldwide.
Diphtheria:
● It
can lead to difficulty breathing,
heart failure, paralysis, or death.
Pertussis:
● It
is also known as “whooping cough,”
can cause uncontrollable, violent coughing that makes it hard to breathe, eat,
or drink.
● Pertussis
can be extremely serious especially in babies and young children, causing
pneumonia, convulsions, brain damage, or death.
● In
teens and adults, it can cause weight loss, loss of bladder control, passing
out, and rib fractures from severe coughing.
Tetanus:
● Tetanus
causes painful stiffening of the
muscles.
● It
can lead to serious health problems, including being unable to open the mouth,
having trouble swallowing and breathing, or death.